XTXXFOTCPharmaceutical PreparationsFiscal year ends December 31

Adastra Holdings Ltd.

Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 20-F on May 17, 2023

$0.01+0.00 (0.00%)

Close on Oct 19, 2026

Adastra Holdings Ltd. income statement

AnnualQuarterlyTTM

CAD USD

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Revenue	10	4.49	1.86
Cost of Revenue	5.52	2.94	1.28
Gross Profit	4.70	1.55	0.59
Research & Development	0	0.07	0.14
General & Administrative	0.53	0.26	0.17
Advertising Expenses	0.98	0.36	0.56
Operating Income	-0.61	-1.91	-5.34
Interest Expense	0.26	0.22	0.30
Pretax Income	-3.33	-2.21	-5.67
Income Tax Expense	-0.04	-0.01	0
Net Income incl. Noncontrolling Interests	-3.29	-2.19	-5.67
EPS (Basic)(per share)	-0.05	-0.04	-0.14
EPS (Diluted)(per share)	-0.05	-0.04	-0.14
Shares Outstanding (Basic, Weighted)(shares)	59	50	40
Shares Outstanding (Diluted, Weighted)(shares)	59	50	40
EBITDA	-0.23	-1.69	-5.27

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2022

Profitability, FY2022

Gross margin: 46.0%
Operating margin: -6.0%
Net margin: –
Return on equity, FY2022: –

Financial strength

Current ratio: 0.71
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.